[PRLD] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[PRLD] Prelude Therapeutics Incorporated
Announcement Date
09-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 11.71%
YoY- 5.87%
Quarter Report
PRLD's Result
PRLD's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -27,718 -28,641 -29,958 -27,374 -29,465 -32,842 -30,687 -6.56%
Tax -1,397 -7,654 -448 -2,087 -823 -168 -356 148.99%
NP -26,321 -20,987 -29,510 -25,287 -28,642 -32,842 -30,687 -9.73%
Tax Rate - - - - - - - -
Total Cost 26,321 20,987 29,510 25,287 28,642 32,842 30,687 -9.73%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.55 -0.44 -0.62 -0.53 -0.61 -0.71 -0.66 -11.45%
EPS Diluted -0.55 -0.44 -0.62 -0.53 -0.61 -0.71 -0.66 -11.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.